Drug Shortage Report for TARO-CLOPIDOGREL
Report ID | 209167 |
Drug Identification Number | 02379813 |
Brand name | TARO-CLOPIDOGREL |
Common or Proper name | CLOPIDOGREL |
Company Name | SUN PHARMA CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | CLOPIDOGREL |
Strength(s) | 75MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 500 |
ATC code | B01AC |
ATC description | ANTITHROMBOTIC AGENTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2023-06-30 |
Estimated end date | 2024-03-29 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2024-01-26 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 126 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2024-01-26 | French | Compare |
v5 | 2024-01-26 | English | Compare |
v4 | 2024-01-05 | French | Compare |
v3 | 2024-01-05 | English | Compare |
v2 | 2023-11-03 | French | Compare |
v1 | 2023-11-03 | English | Compare |
Showing 1 to 6 of 6